William B Schoolcraft

No ORCID on file · 19 papers in corpus · active 2001-2025

Study types

  • article 15
  • other 2
  • review 2

Condition tags

  • endometriosis 18
  • mesh:D004715 7
  • infertility 4
other 2025
Prolonged oral GnRH-antagonist administration before euploid embryo transfer in patients with endometriosis: a prospective randomized pilot non-inferiority trial
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2025.105125

RESEARCH QUESTION: Is oral administration of a gonadotrophin releasing hormone (GnRH) antagonist for 2 months before euploid embryo transfer in patients with endometriosis non-inferior to intramuscular administration of a long-acting GnRH a…

article 2024
ABERRANT MAPK3/1 AND AKT SIGNALING PATHWAYS IN GRANULOSA CELLS MAY CONTRIBUTE TO THE COMPROMISED FOLLICULAR DEVELOPMENT OF THE ENDOMETRIOSIS PATIENTS
·doi:10.1016/j.fertnstert.2024.07.295
article 2024
PROLONGED ORAL GnRH ANTAGONIST ADMINISTRATION PRIOR TO EUPLOID EMBRYO TRANSFER (ET) IN ENDOMETRIOSIS (ENDO) PATIENTS: A PROSPECTIVE RANDOMIZED NON-INFERIORITY TRIAL
·doi:10.1016/j.fertnstert.2024.07.381
article 2023
HYPOXIA CONDITION AND MITOQUINONE TREATMENT RESTORE CELL PROLIFERATION AND MITOCHONDRIAL MEMBRANE POTENTIAL OF GRANULOSA CELLS DERIVED FROM ENDOMETRIOSIS PATIENT DURING IN VITRO CULTURE
·doi:10.1016/j.fertnstert.2023.08.406
article 2018
The impact of infertility diagnosis on embryo-endometrial dialogue
Reproduction (Cambridge, England) ·doi:10.1530/rep-17-0566

Abstract Initial stages of implantation involve bi-directional molecular crosstalk between the blastocyst and endometrium. This study investigated an association between infertility etiologies, specifically advanced maternal age (AMA) and e…

article 2017
GnRH agonist administration prior to embryo transfer in freeze-all cycles of patients with endometriosis or aberrant endometrial integrin expression
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2017.05.004
article 2016
Embryo-endometrial dialogue is altered in endometriosis patients through microRNA regulation
·doi:10.1016/j.fertnstert.2016.07.275
article 2016
Prolonged administration of GnRH agonist (GnRHa) prior to embryo transfer (ET) in endometriosis (ENDO) and integrin (INT)negative patients: the impact of freeze-all cycles
·doi:10.1016/j.fertnstert.2016.07.775
article 2009
Adjuncts for ovarian stimulation: when do we adopt “orphan indications” for approved drugs?
·doi:10.1016/j.fertnstert.2009.03.081
article 2009
Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?
Fertility and sterility ·doi:10.1016/j.fertnstert.2008.12.023
article 2007
Does endometrial αvβ3 vitronectin (β3) expression in endometriosis (ENDO) patients predict enhanced outcomes after prolonged GnRH agonist (GnRHa) therapy prior to in vitro fertilization (IVF)?
·doi:10.1016/j.fertnstert.2007.07.440
other 2007
The incidence of aberrant endometrial alphavbeta(3) vitronectin expression in a high risk infertility population: could prolonged GnRH agonist therapy play a role?
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-007-9164-3

PURPOSE: Evaluate the incidence of aberrant endometrial integrin (alphavbeta(3) vitronectin) expression in patients at high risk for implantation defects. MATERIALS AND METHODS: Retrospective case-control trial of 74 consecutive infertile …

review 2003
Does Surgical Management of Endometriosis Within 6 Months of an In Vitro Fertilization–Embryo Transfer Cycle Improve Outcome?
Journal of assisted reproduction and genetics ·doi:10.1023/a:1025429027610
review 2003
Management of endometriosis-associated infertility
Obstetrics and gynecology clinics of North America ·doi:10.1016/s0889-8545(02)00061-x
article 2003
Tratamiento de la infecundidad relacionada con endometriosis
article 2002
Assisted Reproduction Does Surgical Management of Endometriosis Within 6 Months of an In Vitro Fertilization–Embryo Transfer Cycle Improve Outcome?1

Purpose: To assess the effect on cycle outcome of surgery for endometriosis performed in the 6 months prior to in vitro fertilization–embryo transfer (IVF-ET). Methods: Retrospective analysis of all patients with a primary diagnosis of endo…

article 2002
Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis
Fertility and Sterility ·doi:10.1016/s0015-0282(02)03373-3
article 2001
Does surgical management of endometriosis (ENDO) within 6 months of in vitro fertilization-embryo transfer (IVF-ET) improve cycle outcome?
·doi:10.1016/s0015-0282(01)02312-3
article 2001
The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization-embryo transfer (IVF-ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial.
·doi:10.1016/s0015-0282(01)02442-6